These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1273213)

  • 1. Therapeutical efficacy of a combination of apomorphine with sulpiride or metoclopramide in Parkinsonism.
    Corsini GU; Zompo MD; Cianchetti C; Mangoni A
    Psychopharmacologia; 1976 May; 47(2):169-73. PubMed ID: 1273213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apomorphine hydrochloride-induced improvement in Huntington's chorea: stimulation of dopamine receptor.
    Corsini GU; Onali P; Masala C; Cianchetti C; Mangoni A; Gessa G
    Arch Neurol; 1978 Jan; 35(1):27-30. PubMed ID: 145840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulpiride versus metoclopramide in nononcologic patients with vomiting or nausea.
    Cohen N; Alon I; Almoznino-Sarfian D; Gorelik O; Chachasvili S; Litvinjuk V; Modai D; Weissgarten J
    J Clin Gastroenterol; 1999 Jul; 29(1):59-62. PubMed ID: 10405234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Betamethasone does not prevent nausea and vomiting induced by the dopamine-agonist apomorphine.
    Axelsson P; Thörn SE; Lövqvist A; Wattwil L; Wattwil M
    Can J Anaesth; 2006 Apr; 53(4):370-4. PubMed ID: 16575035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naloxone partly counteracts apomorphine side effects.
    Bonuccelli U; Piccini P; Del Dotto P; Rossi G; Corsini GU; Muratorio A
    Clin Neuropharmacol; 1991 Oct; 14(5):442-9. PubMed ID: 1742754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, placebo-controlled trial of trimethobenzamide to control nausea and vomiting during initiation and continued treatment with subcutaneous apomorphine injection.
    Hauser RA; Isaacson S; Clinch T;
    Parkinsonism Relat Disord; 2014 Nov; 20(11):1171-6. PubMed ID: 25239603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apomorphine in idiopathic restless legs syndrome: an exploratory study.
    Tribl GG; Sycha T; Kotzailias N; Zeitlhofer J; Auff E
    J Neurol Neurosurg Psychiatry; 2005 Feb; 76(2):181-5. PubMed ID: 15654028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An apomorphine-induced vomiting model for antiemetic studies in man.
    Proctor JD; Chremos AN; Evans EF; Wasserman AJ
    J Clin Pharmacol; 1978; 18(2-3):95-9. PubMed ID: 624780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apomorphine (Apokyn) for advanced Parkinson's Disease.
    Med Lett Drugs Ther; 2005 Jan; 47(1200):7-8. PubMed ID: 15647705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A central site of action for benzamide facilitation of gastric emptying.
    Costall B; Gunning SJ; Naylor RJ; Simpson KH
    Eur J Pharmacol; 1983 Jul; 91(2-3):197-205. PubMed ID: 6617741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ondansetron plus dexamethasone compared to the 'standard' metoclopramide combination.
    Roila F
    Oncology; 1993; 50(3):163-7. PubMed ID: 8459986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal apomorphine rescue therapy for parkinsonian "off" periods.
    Dewey RB; Maraganore DM; Ahlskog JE; Matsumoto JY
    Clin Neuropharmacol; 1996 Jun; 19(3):193-201. PubMed ID: 8726538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Modification of extrapyramidal signs by apomorphine associated with various dopaminergic antagonists].
    Pollak P; Gaio JM; Hommel M; Pellat J; Perret J; Chateau R
    Rev Neurol (Paris); 1982; 138(5):409-13. PubMed ID: 7146725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter: Metoclopramide in parkinsonism.
    Tarsy D; Parkes JD; Marsden CD
    Lancet; 1975 May; 1(7918):1244-5. PubMed ID: 48872
    [No Abstract]   [Full Text] [Related]  

  • 15. Metoclopramide and pimozide in Parkinson's disease and levodopa-induced dyskinesias.
    Tarsy D; Parkes JD; Marsden CD
    J Neurol Neurosurg Psychiatry; 1975 Apr; 38(4):331-5. PubMed ID: 1095689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [L-sulpiride versus metoclopramide in functional dyspepsia: a randomized double-blind study].
    Macarri G; Biasi L; Brunelli E; Marucci L; Svegliati Baroni G
    Minerva Med; 1992 May; 83(5):295-8. PubMed ID: 1589135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dopaminergic agonists and antagonists on [3H]apomorphine binding to striatal membranes: sulpiride lack of interactions with positive cooperative [3H]apomorphine binding.
    Fujita N; Saito K; Hirata A; Iwatsubo K; Noguchi Y; Yoshida H
    Brain Res; 1980 Oct; 199(2):335-42. PubMed ID: 7417787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the antiemetic effect of high-dose intravenous metoclopramide and high-dose intravenous haloperidol in a randomized double-blind crossover study.
    Grunberg SM; Gala KV; Lampenfeld M; Jamin D; Johnson K; Cariffe P; Strych D; Krailo M
    J Clin Oncol; 1984 Jul; 2(7):782-7. PubMed ID: 6539812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, cross-over study comparing a levosulpiride-based and a metoclopramide-based combination in the prevention of ProMECE-CytaBOM-induced emesis.
    Sabbatini R; Federico M; Baldini L; Barbieri F; Maiolo MT; Silingardi V
    Haematologica; 1995; 80(5):416-20. PubMed ID: 8566881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [L-dopa-decarboxylase inhibitor combination preparation (Sinemet) in parkinsonism and syndromes imitating parkinsonism. 1 year's experience with 34 patients].
    Holmsen R
    Tidsskr Nor Laegeforen; 1976 Feb; 96(4):225, 234-6. PubMed ID: 1251394
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.